A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly ...

Obesity has emerged as one of the most pressing global health issues, but for women approaching or undergoing menopause, its effects can be even more concerning. While most people associate obesity ...

Health First experts recommend routine screenings, such as annual mammograms starting at age 40, regular cervical cancer screenings.

A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly ...

A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in postmenopausal ...

A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in post-menopausal ...

Postmenopausal women with both CVD and obesity have a higher breast cancer risk than those with obesity alone. The study analyzed data from 168,547 women, revealing a stronger BMI-breast cancer risk ...

The effects of neoadjuvant chemotherapy in postmenopausal women on TSH and fT4, when compared with untreated postmenopausal women with breast cancer, are summarized in (c). Panel A highlights that ...

A 52-year-old woman, 3 years into aromatase inhibitor therapy for stage I hormone receptor–positive breast cancer, reports severe vasomotor symptoms, insomnia, brain fog, arthralgias, dyspareunia, and ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched ...